Fetal fraction of cell-free DNA in maternal plasma in the prediction of spontaneous preterm delivery

Ultrasound in Obstetrics and Gynecology

Volumn 45, Issue 1, 2015, Pages 101-105

  Quezada, M S ^a   Francisco, C ^a   Dumitrascu Biris, D ^a   Nicolaides, K H ^a   Poon, L C ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Cell free dna; Fetal fraction; First trimester screening; Preterm birth

Indexed keywords

BIOLOGICAL MARKER; DNA;

ADULT; BLOOD; CELL FREE SYSTEM; CROSS-SECTIONAL STUDY; CROWN RUMP LENGTH; FEMALE; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; MALE; MATERNAL AGE; NEWBORN; PREDICTIVE VALUE; PREGNANCY; PREMATURE BIRTH; PREMATURE FETUS MEMBRANE RUPTURE;

ADULT; BIOLOGICAL MARKERS; CELL-FREE SYSTEM; CROSS-SECTIONAL STUDIES; CROWN-RUMP LENGTH; DNA; FEMALE; FETAL MEMBRANES, PREMATURE RUPTURE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; MALE; MATERNAL AGE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREMATURE BIRTH;

EID: 84920768414     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.14666     Document Type: Article

References (19)

1. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008; 371: 261-269.
2. Centre for Maternal and Child Enquiries (CMACE). Perinatal Mortality 2008: United Kingdom. CMACE: London, 2010.
3. Beta J, Akolekar R, Ventura W, Syngelaki A, Nicolaides KH. Prediction of spontaneous preterm delivery from maternal factors, obstetric history and placental perfusion and function at 11-13 weeks. Prenat Diagn 2011; 31: 75-83.
4. Beta J, Bredaki FE, Rodriguez Calvo J, Akolekar R, Nicolaides KH. Maternal serum α-fetoprotein at 11 to 13 weeks' gestation in spontaneous early preterm delivery. Fetal Diagn Ther 2011; 30: 88-93.
5. Greco E, Gupta R, Syngelaki A, Poon LCY, Nicolaides KH. First-trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length. Fetal Diagn Ther 2012; 31: 154-161.
6. Leung TN, Zhang J, Lau TK, Hjelm NM, Lo YM. Maternal plasma fetal DNA as a marker for preterm labour. Lancet 1998; 352: 1904-1905.
7. Farina A, LeShane ES, Romero R, Gomez R, Chaiworapongsa T, Rizzo N, Bianchi DW. High levels of fetal cell-free DNA in maternal serum: a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2005; 193: 421-425.
8. Bianchi DW. Fetal DNA in maternal plasma: the plot thickens and the placental barrier thins. Am J Hum Genet 1998; 62: 763-764.
9. Jakobsen TR, Clausen FB, Rode L, Dziegiel MH, Tabor A. High levels of fetal DNA are associated with increased risk of spontaneous preterm delivery. Prenat Diagn 2012; 32: 840-845.
10. Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW, Pertl B. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome. Prenat Diagn 2006; 26: 831-836.
11. Illanes S, Gomez R, Fornes R, Figueroa-Diesel H, Schepeler M, Searovic P, Serra R, Perez A, Nien JK. Free fetal DNA levels in patients at risk of preterm labour. Prenat Diagn 2011; 31: 1082-1085.
12. Stein W, Müller S, Gutensohn K, Emons G, Legler T. Cell-free fetal DNA and adverse outcome in low risk pregnancies. Eur J Obstet Gynecol Reprod Biol 2013; 166: 10-13.
13. Robinson HP, Fleming JE. A critical evaluation of sonar "crown-rump length" measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
14. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 319.e1-9.
15. Ashoor G, Syngelaki A, Wagner M, Birdir C, Nicolaides KH. Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012; 206: 322.e1-5.
16. Ashoor G, Syngelaki A, Wang E, Struble C, Oliphant A, Song K, Nicolaides KH. Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method. Ultrasound Obstet Gynecol 2013; 41: 21-25.
17. Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH. Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks' gestation: relation to fetal and maternal characteristics and pregnancy outcomes. Fetal Diagn Ther 2013; 33: 215-223.
18. Conde-Agudelo A, Romero R, Nicolaides K, Chaiworapongsa T, O'Brien JM, Cetingoz E, da Fonseca E, Creasy G, Soma-Pillay P, Fusey S, Cam C, Alfirevic Z, Hassan SS. Vaginal progesterone vs. cervical cerclage for the prevention of preterm birth in women with a sonographic short cervix, previous preterm birth, and singleton gestation: a systematic review and indirect comparison metaanalysis. Am J Obstet Gynecol 2013; 208: 42.e1-42.e18.
19. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther 2014; 35: 156-173.